New York Stem Cell Foundation

Last updated
The New York Stem Cell Foundation
Formation2005
FounderSusan L. Solomon, Mary Elizabeth Bunzel
Type Non-profit Research Institute
HeadquartersNew York City
CEO
Derrick J. Rossi, PhD
Website https://nyscf.org/

The New York Stem Cell Foundation, or NYSCF, is an American non-profit research institute focused on stem cell research, technology development, and funding researchers. [1] Headquartered on the far west side of Manhattan, New York, NYSCF employs 114 scientists, technicians, engineers, and administrative and other staff, [2] in addition to funding early career investigators and postdoctoral fellows. Since its inception, NYSCF has raised and invested more than $400 million for stem cell research. [2]

Contents

Organization

History

NYSCF was founded in New York City by Susan L. Solomon, a lawyer and entrepreneur, and Mary Elizabeth Bunzel, a former journalist, in 2005 to accelerate stem cell-based approaches to researching and treating type 1 diabetes [3] and in response to the refusal of the administration of President George W. Bush to make a major investment in stem cell research. [1] In 2006, NYSCF opened the NYSCF Research Institute – a 500 square foot, one-room independent laboratory located adjacent to Columbia University [4] [5] – as a safe-haven to conduct somatic cell nuclear transfer research through a collaboration with Columbia University and Harvard University. [6]

In 2015, NYSCF signed a 20-year lease to move its headquarters and NYSCF Research Institute laboratories to a renovated 42,000 square foot space at 619 West 54th Street [7] in the former Warner Brothers 'Movie Lab' building, [8] [9] rebranded as the Hudson Research Center by commercial real estate developer and building owner Taconic. [10] Opened in 2017, the new headquarters includes space for a Good Manufacturing Practice facility to manufacture cells for clinical trials. [11] In 2021, New York City announced it would grant NYSCF $6.5M as one of four applied research and development (R&D) facilities to equip an expansion of its Research Institute. [12]

Corporate leadership

The NYSCF is currently led by Jennifer J. Raab, former President of Hunter College. Raab was appointed as President & Chief Executive Officer in January 2024. [13]

The board of directors includes Roy Geronemus, Stephen M. Ross, Stephen Scherr, Kay Unger, Paul Goldberger, and Siddhartha Mukherjee. [14]

Research

High-throughput technologies

In 2015, NYSCF described the development of the NYSCF Global Stem Cell Array, a fully-automated system for high-throughput creation, differentiation, and quality control of stem cell lines. [15] [16] The system saves five to six times the cost of reagents as compared to manual stem cell derivation. [15] [16] The Global Stem Cell Array has been used to conduct research on several patient groups including children with rare diseases, [17] veterans with post-traumatic stress disorder, [18] [19] and Parkinson’s patients. [20] [21]

Stem cell-based research

NYSCF research resulting in the first human stem cell lines from the cells of patients with amyotrophic lateral sclerosis (ALS), commonly known as Lou Gehrig’s disease, was named as Time magazine's top medical breakthrough of 2008 and the number one breakthrough of the year by Science magazine. [22] [23] In 2018, a phase 2 clinical trial for Ezogabine, an epilepsy treatment identified as a possible ALS therapy based on this human stem cell model, was shown to reduce motor neuron excitability in ALS patients. [24] [25]

In 2013, NYSCF researchers created the first patient-specific bone from stem cells and successfully transplanted the grafts into mice. [26] [27]

NYSCF researchers created stem cells and derived neurons from a pair of identical twins, one with Parkinson’s disease and one without, finding their neurons differed in how they produce the neurotransmitter dopamine and the enzyme beta-glucocerebrosidase in addition to differing in a molecular signaling pathway. [28] [29]

NYSCF researchers, in collaboration with researchers at New York University, created astrocytes from human stem cells and showed that in disease-like environments these cells can turn into neuron killers. [30] [31]

Mitochondrial replacement therapy

NYSCF researchers developed mitochondrial replacement therapy in 2012, or MRT, a technique to prevent the mother-to-child transmission of mitochondrial diseases [32] [33] [3] [34] which is now approved for clinical use in the United Kingdom. [35]

Artificial intelligence

With Google Research, NYSCF scientists used the NYSCF Array and artificial intelligence algorithms to identify new cellular features of Parkinson’s disease by analyzing over six million images of skin cells, sampled and expanded from a group of 91 Parkinson’s patients and healthy controls. [20] [36]

Partnerships

Organizations NYSCF has or is currently partnering with include: Google; [36] the Icahn School of Medicine at Mount Sinai, the James J. Peters Veterans Affairs Medical Center, and Yale University School of Medicine; [19] Rush University Medical Center, Harvard Medical School, and Brigham and Women’s Hospital; [37] Johns Hopkins School of Medicine and Bloomberg Philanthropies; [38] [39] and Columbia University Medical Center and the National Eye Institute. [40]

Activism

NYSCF started a working group "Initiative on Women in Science and Engineering" (IWISE) to address gender equality in science and STEM fields. [41] The IWISE working group published seven actionable strategies for institutions to promote gender equity in a 2015 Cell Stem Cell paper. [41] [42] One of these steps is an Institutional Report Card for Gender Equality, which NYSCF created and requires every NYSCF grant applicant to fill out. The results of a 5-year analysis of these report card submissions were published in a 2019 Cell Stem Cell paper defining the extent of gender parity issues in the academic pipeline and opportunities for improvement. [43]

Funding

NYSCF was founded with private philanthropy from individuals and foundations. Notable early funders include former New York City mayor Michael R. Bloomberg; the investor Stanley Druckenmiller and his wife, Fiona; and a foundation founded by the late hedge-fund manager Julian Robertson. [1]

NYSCF hosts an annual fundraising Gala and Science Fair. Past honorees include Janet and Jerry Zucker, Sanjay Gupta, MD; Siddhartha Mukherjee, MD, DPhil; Irving Weissman, MD; Susan and Stephen Scherr; Victor Garber; Derrick Rossi, PhD; Kizzmekia Corbett, PhD; Barney Graham, MD, PhD; Katalin Karikó, PhD; Drew Weissman, MD, PhD; Brooke Ellison; Frank Gehry; and David Rockwell. [44] [45] [46] [47] [48] In 2021 and 2020, NYSCF held virtual Galas both directed by Scott Ellis and hosted by Sanjay Gupta, MD. [45]

In addition to philanthropy, NYSCF also receives funding from grants, partnerships, and collaborations.[ citation needed ]

Awards

Several awards are administered by the NYSCF. The Robertson Early Career Investigator Awards are given to scientists who have recently launched their own laboratories and provides unrestricted funding over a five-year period to scientists around the world, funded by the Robertson Foundation since 2010. [49] [50] The Druckenmiller Postdoctoral Fellows Awards provide three years of unrestricted funding to postdoctoral stem cell researchers in the tri-state area of New York, New Jersey and Connecticut, and are funded by Stanley and Fiona Druckenmiller. [51] [52]

Notable recipients of NYSCF awards include Feng Zhang, Edward Boyden, Jayaraj Rajagopal, Paola Arlotta, Valentina Greco Lydia W. S. Finley, Shruti Naik, Lauren Orefice, Lauren O’Connell, Elaine Hsiao, Carolyn (Lindy) McBride, Paul J. Tesar, Vanessa Ruta, Edward Chang, Lisa Giocomo, Kay Tye, Dragana Rogulja, Maria Lehtinen, Claire Wyart, Sergiu P. Pașca, Ilana B. Witten, Franziska Michor, and Amy Wagers.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Somatic cell nuclear transfer</span> Method of creating a cloned embryo by replacing the egg nucleus with a body cell nucleus

In genetics and developmental biology, somatic cell nuclear transfer (SCNT) is a laboratory strategy for creating a viable embryo from a body cell and an egg cell. The technique consists of taking a denucleated oocyte and implanting a donor nucleus from a somatic (body) cell. It is used in both therapeutic and reproductive cloning. In 1996, Dolly the sheep became famous for being the first successful case of the reproductive cloning of a mammal. In January 2018, a team of scientists in Shanghai announced the successful cloning of two female crab-eating macaques from foetal nuclei.

<span class="mw-page-title-main">MPTP</span> Chemical compound

MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) is an organic compound. It is classified as a tetrahydropyridine. It is of interest as a precursor to the neurotoxin MPP+, which causes permanent symptoms of Parkinson's disease by destroying dopaminergic neurons in the substantia nigra of the brain. It has been used to study disease models in various animals.

<span class="mw-page-title-main">Adult neurogenesis</span> Generating of neurons from neural stem cells in adults

Adult neurogenesis is the process in which neurons are generated from neural stem cells in the adult. This process differs from prenatal neurogenesis.

<span class="mw-page-title-main">Embryonic stem cell</span> Type of pluripotent blastocystic stem cell

Embryonic stem cells (ESCs) are pluripotent stem cells derived from the inner cell mass of a blastocyst, an early-stage pre-implantation embryo. Human embryos reach the blastocyst stage 4–5 days post fertilization, at which time they consist of 50–150 cells. Isolating the inner cell mass (embryoblast) using immunosurgery results in destruction of the blastocyst, a process which raises ethical issues, including whether or not embryos at the pre-implantation stage have the same moral considerations as embryos in the post-implantation stage of development.

<span class="mw-page-title-main">Neurodegenerative disease</span> Central nervous system disease

A neurodegenerative disease is caused by the progressive loss of neurons, in the process known as neurodegeneration. Neuronal damage may also ultimately result in their death. Neurodegenerative diseases include amyotrophic lateral sclerosis, multiple sclerosis, Parkinson's disease, Alzheimer's disease, Huntington's disease, multiple system atrophy, tauopathies, and prion diseases. Neurodegeneration can be found in the brain at many different levels of neuronal circuitry, ranging from molecular to systemic.Because there is no known way to reverse the progressive degeneration of neurons, these diseases are considered to be incurable; however research has shown that the two major contributing factors to neurodegeneration are oxidative stress and inflammation. Biomedical research has revealed many similarities between these diseases at the subcellular level, including atypical protein assemblies and induced cell death. These similarities suggest that therapeutic advances against one neurodegenerative disease might ameliorate other diseases as well.

<span class="mw-page-title-main">Glial cell line-derived neurotrophic factor</span> Protein-coding gene in the species Homo sapiens

Glial cell line-derived neurotrophic factor (GDNF) is a protein that, in humans, is encoded by the GDNF gene. GDNF is a small protein that potently promotes the survival of many types of neurons. It signals through GFRα receptors, particularly GFRα1. It is also responsible for the determination of spermatogonia into primary spermatocytes, i.e. it is received by RET proto-oncogene (RET) and by forming gradient with SCF it divides the spermatogonia into two cells. As the result there is retention of spermatogonia and formation of spermatocyte.

Neural stem cells (NSCs) are self-renewing, multipotent cells that firstly generate the radial glial progenitor cells that generate the neurons and glia of the nervous system of all animals during embryonic development. Some neural progenitor stem cells persist in highly restricted regions in the adult vertebrate brain and continue to produce neurons throughout life. Differences in the size of the central nervous system are among the most important distinctions between the species and thus mutations in the genes that regulate the size of the neural stem cell compartment are among the most important drivers of vertebrate evolution.

<span class="mw-page-title-main">Gladstone Institutes</span>

Gladstone Institutes is an independent, non-profit biomedical research organization whose focus is to better understand, prevent, treat and cure cardiovascular, viral and neurological conditions such as heart failure, HIV/AIDS and Alzheimer's disease. Its researchers study these diseases using techniques of basic and translational science. Another focus at Gladstone is building on the development of induced pluripotent stem cell technology by one of its investigators, 2012 Nobel Laureate Shinya Yamanaka, to improve drug discovery, personalized medicine and tissue regeneration.

Lorenz Studer is a Swiss biologist. He is the founder and director of the Center for Stem Cell Biology at Memorial-Sloan Kettering Cancer Center in New York City. He is a developmental biologist and neuroscientist who is pioneering the generation of midbrain dopamine neurons for transplantation and clinical applications. His expertise in cell engineering spans a wide range of cells/tissues within the nervous system geared toward disease modeling and exploring cell replacement therapy. Currently, he is a member of the Developmental Biology Program and Department of Neurosurgery at Memorial Sloan-Kettering Cancer Center and a Professor of Neuroscience at Weill Cornell Medical College in New York City, NY.

<span class="mw-page-title-main">Jeanne Loring</span> American biologist

Jeanne Frances Loring is an American stem cell biologist, developmental neurobiologist, and geneticist. She is the founding Director of the Center for Regenerative Medicine and emeritus professor at the Scripps Research Institute in La Jolla, California. She has founded two biotechnology companies, Arcos BioScience (1999) and Aspen Neuroscience (2018)

Research on amyotrophic lateral sclerosis (ALS) has focused on animal models of the disease, its mechanisms, ways to diagnose and track it, and treatments.

Viviane Tabar is an American neurosurgeon, the Chair of the Department of Neurosurgery at Memorial Sloan Kettering Cancer Center in New York since 2017.

<span class="mw-page-title-main">Cell-based therapies for Parkinson's disease</span> Treatment method for Parkinsons disease

Cell-based therapies for Parkinson's disease include various investigational procedures which transplant specific populations of cells into the brains of people with Parkinson's disease. The investigation of cell transplantation therapies followed the discovery that the death of dopaminergic neurons in the substantia nigra pars compacta resulted in the motor symptoms of the disease. Thus, cell transplantation has focused on various dopamine producing cells throughout the body.

<span class="mw-page-title-main">Shake it Up Australia Foundation</span> Australian non-for-profit foundation

The Shake It Up Australia Foundation (SIUAF) is an Australian non-for-profit foundation founded in 2011 by Clyde and Greg Campbell. It is partnered with the Michael J. Fox Foundation (MJFF) to achieve the foundations primary aims of "promoting and funding Parkinson's disease research in Australia to slow, stop and cure the disease". Together MJFF and SIUAF are the largest non-government funders of Parkinson's research across multiple institutes in Australia. Since its founding, the foundation has co-founded 38 Parkinson's research projects across 12 institutes to the value of over $10.8 million. The foundation's funding model ensures that 100% of proceeds goes towards Parkinson's research in Australia. This is possible due to the founding directors covering all overhead costs and expenses. In January 2019, Shake It Up are one of the partner organisation in the Australian Parkinson's Mission which was awarded a $30 million-dollar grant to test repurposed drugs in clinical trials.

<span class="mw-page-title-main">Experimental models of Alzheimer's disease</span>

Experimental models of Alzheimer's disease are organism or cellular models used in research to investigate biological questions about Alzheimer's disease as well as develop and test novel therapeutic treatments. Alzheimer's disease is a progressive neurodegenerative disorder associated with aging, which occurs both sporadically or due to familial passed mutations in genes associated with Alzheimer's pathology. Common symptoms associated with Alzheimer's disease include: memory loss, confusion, and mood changes.

<span class="mw-page-title-main">Anders Björklund</span> Swedish neuroscientist (born 1945)

Anders Björklund is a Swedish neuroscientist and pioneer in the study of cell- and gene-based reparative and neuroprotective mechanisms in the brain. He has spent his academic career at Lund University in Sweden, as professor since 1983 and as senior professor at the Wallenberg Neuroscience Center since his formal retirement in 2012.

Dimitri Krainc is a Slovenian-born American physician-scientist who is the Aaron Montgomery Ward Professor and Chairman of the Ken & Ruth Davee Department of Neurology and Director of the Feinberg Neuroscience Institute and the Simpson Querrey Center for Neurogenetics at Northwestern University Feinberg School of Medicine. After completing his medical training at the University of Zagreb, Krainc spent more than two decades at the Massachusetts General Hospital and Harvard Medical School, where he completed his research and clinical training and served on faculty until relocating to Northwestern University in 2013. He has dedicated his scientific career to studying molecular pathways in the pathogenesis of neurodegeneration. Informed by genetic causes of disease, his work has uncovered key mechanisms across different neurodegenerative disorders that have led to pioneering design and development of targeted therapies. He has received numerous awards and recognitions for his work, including the Javits Neuroscience Investigator Award and the Outstanding Investigator award from NIH, and was elected to the Association of American Physicians, the National Academy of Medicine, the National Academy of Inventors and the Croatian Academy of Sciences and Arts He is the principal founding scientist of two biotech companies and serves as Venture Partner at OrbiMed. Krainc is President-elect of the American Neurological Association.

Valentina Fossati is an Italian stem cell biologist. She is a Senior Research Investigator at the New York Stem Cell Foundation. Her research is focused on developing human stem cell-based models to study the role of glia in neurodegeneration and neuroinflammation.

Lezanne Ooi is an Australian neuroscientist who is Professor and Head of Neurodevelopment at the University of Wollongong. Her research considers the development of cellular imaging techniques to understand neurodegenerative disease.

Zhenyu Yue is a Chinese academic researcher in the field of neurology and neuroscience, who is the Alex and Shirley Aidekman Professor at the Icahn School of Medicine at Mount Sinai, New York. He is known for his discovery of genes controlling autophagy, autophagy functions in central nervous system, molecular mechanism of neurodegenerative diseases, and modelling neurological diseases using genetic mouse models.

References

  1. 1 2 3 Roberts, Sam (2022-09-13). "Susan L. Solomon, Crusader for Stem Cell Research, Dies at 71". The New York Times. ISSN   0362-4331 . Retrieved 2023-04-25.
  2. 1 2 Hagerty, James R. "Susan L. Solomon Led Drive to Accelerate Stem-Cell Research". WSJ. Retrieved 2023-04-25.
  3. 1 2 Wolfe, Alexandra (2016-02-05). "Susan L. Solomon's Stem-Cell Research Quest". WSJ. Retrieved 2023-04-25.
  4. ↑ "Field of vision". Crain's New York Business. 2012-06-10. Retrieved 2023-04-25.
  5. ↑ "Pioneers". Science. 314 (5803): 1223. 2006-11-24. doi:10.1126/science.314.5803.1223a. ISSN   0036-8075. S2CID   220083371.
  6. ↑ Bioengineer (2014-04-28). "First disease-specific human embryonic stem cell line by nuclear transfer". bioengineer.org. Retrieved 2023-05-03.
  7. ↑ Nonko, Emily (2015-11-29). "Stem-Cell Leader Expands in New York". WSJ. Retrieved 2023-04-25.
  8. ↑ Weiss, Lois (2017-08-16). "Movie Lab building transforming into science lab". New York Post. Retrieved 2023-05-01.
  9. ↑ Coste, Mihaela (2017-05-05). "Manhattan Office Asset Lands $200M Recap". Commercial Property Executive. Retrieved 2023-04-25.
  10. ↑ Cunningham, Cathy (2020-12-23). "Silverstein, Taconic Seal $205M Refi for NYC Life Science Asset". Commercial Observer. Retrieved 2023-05-01.
  11. ↑ "How Real Estate is Preparing for the Emergence of the Life Sciences Industry in NYC". Commercial Observer. 2018-07-15. Retrieved 2023-05-01.
  12. ↑ "State of the City Preview: New York City Invests $38 Million in New Biotech Centers". The official website of the City of New York. 2021-01-21. Retrieved 2023-04-25.
  13. ↑ Barron, James (2024-01-31). "A New Gig in the Science World". The New York Times. ISSN   0362-4331 . Retrieved 2024-05-05.
  14. ↑ "Archives". New York Stem Cell Foundation. Retrieved 2024-05-05.
  15. 1 2 "Pluripotency Bots". The Scientist Magazine®. Retrieved 2023-04-25.
  16. 1 2 Paull, Daniel; Sevilla, Ana; Zhou, Hongyan; Hahn, Aana Kim; Kim, Hesed; Napolitano, Christopher; Tsankov, Alexander; Shang, Linshan; Krumholz, Katie; Jagadeesan, Premlatha; Woodard, Chris M.; Sun, Bruce; Vilboux, Thierry; Zimmer, Matthew; Forero, Eliana (2015-08-03). "Automated, high-throughput derivation, characterization and differentiation of induced pluripotent stem cells". Nature Methods. 12 (9): 885–892. doi:10.1038/nmeth.3507. ISSN   1548-7105. PMID   26237226. S2CID   9889991.
  17. ↑ "'Something positive for humankind': Girls lend cells to genetic study". NBC News. 8 December 2013. Retrieved 2023-04-25.
  18. ↑ "Stem Cell Study Reveals How Neurons From PTSD Patients React to Stress | Mount Sinai - New York". Mount Sinai Health System. Retrieved 2023-04-25.
  19. 1 2 Ktori, Sophia (2022-10-21). "Stem Cell Study Shows How Neurons from PTSD Patients React to Stress". GEN - Genetic Engineering and Biotechnology News. Retrieved 2023-04-25.
  20. 1 2 "How Google is helping shape the future of AI in health care". GC innovate (in Flemish). 2022-05-02. Retrieved 2023-04-25.
  21. ↑ Ktori, Sophia (2022-03-28). "AI and Robotics Uncover Cellular Hallmarks of Parkinson's in Skin Cells". GEN - Genetic Engineering and Biotechnology News. Retrieved 2023-04-25.
  22. ↑ Park, Alice (2008-11-03). "The Top 10 Everything of 2008 - TIME". Time. ISSN   0040-781X . Retrieved 2023-04-25.
  23. ↑ Vogel, Gretchen (2008-12-19). "Reprogramming Cells". Science. 322 (5909): 1766–1767. doi:10.1126/science.322.5909.1766. ISSN   0036-8075. PMID   19095902. S2CID   10410812.
  24. ↑ "Ezogabine treatment shown to reduce motor neuron excitability in ALS patients". medicalxpress.com. Retrieved 2023-04-25.
  25. ↑ Wainger, Brian J.; Macklin, Eric A.; Vucic, Steve; McIlduff, Courtney E.; Paganoni, Sabrina; Maragakis, Nicholas J.; Bedlack, Richard; Goyal, Namita A.; Rutkove, Seward B.; Lange, Dale J.; Rivner, Michael H.; Goutman, Stephen A.; Ladha, Shafeeq S.; Mauricio, Elizabeth A.; Baloh, Robert H. (2021-02-01). "Effect of Ezogabine on Cortical and Spinal Motor Neuron Excitability in Amyotrophic Lateral Sclerosis: A Randomized Clinical Trial". JAMA Neurology. 78 (2): 186–196. doi:10.1001/jamaneurol.2020.4300. ISSN   2168-6149. PMC   7684515 . PMID   33226425.
  26. ↑ Naik, Gautam (2013-05-06). "Scientists Make Human Bone From Skin Cells". WSJ. Retrieved 2023-04-25.
  27. ↑ de Peppo, Giuseppe Maria; Marcos-Campos, Iván; Kahler, David John; Alsalman, Dana; Shang, Linshan; Vunjak-Novakovic, Gordana; Marolt, Darja (2013-05-21). "Engineering bone tissue substitutes from human induced pluripotent stem cells". Proceedings of the National Academy of Sciences. 110 (21): 8680–8685. Bibcode:2013PNAS..110.8680D. doi: 10.1073/pnas.1301190110 . ISSN   0027-8424. PMC   3666730 . PMID   23653480.
  28. ↑ Henig, Robin Marantz (2015-02-23). "Did Grief Give Him Parkinson's?". Nautilus. Retrieved 2023-04-25.
  29. ↑ Woodard, Chris M.; Campos, Brian A.; Kuo, Sheng-Han; Nirenberg, Melissa J.; Nestor, Michael W.; Zimmer, Matthew; Mosharov, Eugene V.; Sulzer, David; Zhou, Hongyan; Paull, Daniel; Clark, Lorraine; Schadt, Eric E.; Sardi, Sergio Pablo; Rubin, Lee; Eggan, Kevin (2014-11-20). "iPSC-Derived Dopamine Neurons Reveal Differences between Monozygotic Twins Discordant for Parkinson's Disease". Cell Reports. 9 (4): 1173–1182. doi:10.1016/j.celrep.2014.10.023. ISSN   2211-1247. PMC   4255586 . PMID   25456120.
  30. ↑ Jackson, Christina (2020-06-02). "Stem Cell Model Exposes Astrocytes as Potential Mechanism behind Neurodegeneration". GEN - Genetic Engineering and Biotechnology News. Retrieved 2023-04-25.
  31. ↑ Barbar, Lilianne; Jain, Tanya; Zimmer, Matthew; Kruglikov, Ilya; Sadick, Jessica S.; Wang, Minghui; Kalpana, Kriti; Rose, Indigo V.L.; Burstein, Suzanne R.; Rusielewicz, Tomasz; Nijsure, Madhura; Guttenplan, Kevin A.; di Domenico, Angelique; Croft, Gist; Zhang, Bin (2020-08-05). "CD49f Is a Novel Marker of Functional and Reactive Human iPSC-Derived Astrocytes". Neuron. 107 (3): 436–453.e12. doi:10.1016/j.neuron.2020.05.014. ISSN   0896-6273. PMC   8274549 . PMID   32485136.
  32. ↑ Farrell, John (2012-12-19). "Nuclear Transfer Breakthrough Offers A Way To Prevent Mitochondrial Disorders". Forbes. Retrieved 2023-04-25.
  33. ↑ Tingley, Kim (2014-06-27). "The Brave New World of Three-Parent I.V.F." The New York Times. ISSN   0362-4331 . Retrieved 2023-04-25.
  34. ↑ Paull, Daniel; Emmanuele, Valentina; Weiss, Keren A.; Treff, Nathan; Stewart, Latoya; Hua, Haiqing; Zimmer, Matthew; Kahler, David J.; Goland, Robin S.; Noggle, Scott A.; Prosser, Robert; Hirano, Michio; Sauer, Mark V.; Egli, Dieter (2012-12-19). "Nuclear genome transfer in human oocytes eliminates mitochondrial DNA variants". Nature. 493 (7434): 632–637. doi:10.1038/nature11800. ISSN   1476-4687. PMC   7924261 . PMID   23254936.
  35. ↑ Guilford, Gwynn (2015-02-03). "Make way for three-parent babies". Quartz. Retrieved 2023-04-25.
  36. 1 2 Schiff, Lauren; Migliori, Bianca; Chen, Ye; Carter, Deidre; Bonilla, Caitlyn; Hall, Jenna; Fan, Minjie; Tam, Edmund; Ahadi, Sara; Fischbacher, Brodie; Geraschenko, Anton; Hunter, Christopher J.; Venugopalan, Subhashini; DesMarteau, Sean; Narayanaswamy, Arunachalam (2022-03-25). "Integrating deep learning and unbiased automated high-content screening to identify complex disease signatures in human fibroblasts". Nature Communications. 13 (1): 1590. Bibcode:2022NatCo..13.1590S. doi:10.1038/s41467-022-28423-4. ISSN   2041-1723. PMC   8956598 . PMID   35338121.
  37. ↑ Lagomarsino, Valentina N.; Pearse, Richard V.; Liu, Lei; Hsieh, Yi-Chen; Fernandez, Marty A.; Vinton, Elizabeth A.; Paull, Daniel; Felsky, Daniel; Tasaki, Shinya; Gaiteri, Chris; Vardarajan, Badri; Lee, Hyo; Muratore, Christina R.; Benoit, Courtney R.; Chou, Vicky (2021-11-03). "Stem cell-derived neurons reflect features of protein networks, neuropathology, and cognitive outcome of their aged human donors". Neuron. 109 (21): 3402–3420.e9. doi:10.1016/j.neuron.2021.08.003. ISSN   0896-6273. PMC   8571042 . PMID   34473944.
  38. ↑ "Johns Hopkins School of Medicine announces new partnership to advance precision medicine". The Hub. 2019-10-22. Retrieved 2023-04-25.
  39. ↑ "Bloomberg Philanthropies, Johns Hopkins University School of Medicine, and The New York Stem Cell Foundation Research Institute Announce an Unprecedented Effort to Advance Precision Medicine". Bloomberg Philanthropies. Retrieved 2023-04-25.
  40. ↑ "AMD Integrative Biology Initiative | National Eye Institute". www.nei.nih.gov. Retrieved 2023-04-25.
  41. 1 2 Smith, Kristin A.; Arlotta, Paola; Watt, Fiona M.; Solomon, Susan L.; Bargmann, Cori; Berg, David; Briggs, LaTese; Chao, Moses V.; Dulac, Catherine; Eggan, Kevin; Escobar-Alvarez, Sindy; Fossati, Valentina; Fuchs, Elaine; Glimcher, Laurie H. (2015-03-05). "Seven Actionable Strategies for Advancing Women in Science, Engineering, and Medicine". Cell Stem Cell. 16 (3): 221–224. doi:10.1016/j.stem.2015.02.012. ISSN   1934-5909. PMC   4476252 . PMID   25748929.
  42. ↑ "Seven strategies for keeping women in STEM fields". Reuters. 2015-03-16. Retrieved 2023-04-25.
  43. ↑ Beeler, Whitney H.; Smith-Doody, Kristin A.; Ha, Richard; Aiyar, Raeka S.; Schwarzbach, Elizabeth; Solomon, Susan L.; Jagsi, Reshma (2019-09-05). "Institutional Report Cards for Gender Equality: Lessons Learned from Benchmarking Efforts for Women in STEM". Cell Stem Cell. 25 (3): 306–310. doi: 10.1016/j.stem.2019.08.010 . ISSN   1934-5909. PMID   31491394. S2CID   201869532.
  44. ↑ "Honorees – NYSCF Gala & Science Fair" . Retrieved 2023-04-25.[ permanent dead link ]
  45. 1 2 "Past Galas – NYSCF Gala & Science Fair" . Retrieved 2023-04-25.
  46. ↑ Cristi, A. A. "Tony-Winner David Rockwell to Be Honored By NYSCF As Part Of First Ever Virtual Gala". BroadwayWorld.com. Retrieved 2023-04-25.
  47. ↑ Rabinowitz, Chloe. "Victor Garber to be Honored at SHOW UP FOR SCIENCE Event, Featuring Jane Krakowski, Tony Shalhoub, Jesse Williams & More". BroadwayWorld.com. Retrieved 2023-04-25.
  48. ↑ Rosky, Nicole. "Photos: Caissie Levy, Annaleigh Ashford & More Come Out to Support the New York Stem Cell Foundation". BroadwayWorld.com. Retrieved 2023-11-03.
  49. ↑ "Hedge-Fund Founder Julian Robertson Donates $27M to Fund Stem-Cell Research". WSJ. Retrieved 2023-04-25.
  50. ↑ "NYSCF – Robertson Stem Cell Investigator Awards". New York Stem Cell Foundation. Retrieved 2023-04-25.
  51. ↑ "NYSCF – Druckenmiller Fellowship Awards". New York Stem Cell Foundation. Retrieved 2023-04-25.
  52. ↑ Di Mento, Maria (2010-01-04). "Druckenmiller Foundation Announces $705 Million in Gifts From Founders". Philanthropy News Digest. Retrieved 2023-05-01.

Official website

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.